Stock A228760 GENOMICTREE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Genomictree Inc.

Equities

A228760

KR7228760005

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
20,150 KRW -1.71% Intraday chart for Genomictree Inc. -3.36% -2.18%
2023 Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2022 Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.
CI
Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.
CI
Genomictree Inc.'s Equity Buyback announced on May 17, 2022, has expired with 380,360 shares, representing 1.86% for KRW 4,984.4 million.
CI
Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.
CI
Genomictree Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.
CI
Genomictree Inc. Ltd authorizes a Buyback Plan.
CI
Genomictree Inc. announced that it has received KRW 5.00000105 billion in funding from ORION Holdings Corp.
CI
Genomictree Inc. announced that it expects to receive KRW 5.00000105 billion in funding from ORION Holdings Corp.
CI
Genomictree Inc. agreed to acquire 4.8% stake in optoLANE Technologies Inc for KRW 5 billion.
CI
Genomictree Inc. announced that it has received KRW 59.9999768 billion in funding from a group of investors
CI
Genomictree Inc. announced that it expects to receive KRW 59.9999768 billion in funding from a group of investors
CI
Promis Diagnostics, Inc. announced that it has received $19.99999 million in funding from Genomictree Inc.
CI
Genomictree Inc.(KOSDAQ:A228760) added to S&P Global BMI Index
CI
Genomictree Inc. announced that it has received KRW 7 billion in funding
CI
Genomictree Inc. announced that it expects to receive KRW 7 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A228760 Stock
  4. News Genomictree Inc.